Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 28, 2024
Dec. 30, 2023
Current Assets    
Cash and cash equivalents $ 149.3 $ 171.7
Accounts receivable, less allowance for credit losses of $18.1 and $3.6 as of December 28, 2024 and December 30, 2023, respectively 136.5 174.1
Contract assets 23.2 49.7
Inventories 53.3 48.4
Prepaid expenses 7.2 8.4
Other current assets 16.0 10.8
Total current assets 385.5 463.1
Property, plant and equipment, net 56.8 52.4
Right-of-use assets, net 59.7 50.9
Intangible assets, net 373.5 375.3
Goodwill 383.1 368.6
Deferred tax assets, net 36.9 36.8
Other assets 5.8 2.9
Total assets 1,301.3 1,350.0
Current Liabilities    
Accounts payable 53.9 59.8
Contract liabilities 17.9 26.7
Current maturities of long-term debt 8.8 7.3
Accrued expenses and other current liabilities 56.2 80.3
Total current liabilities 136.8 174.1
Long-term debt, net 583.2 607.7
Deferred tax liabilities, net 1.7 1.7
Other long-term liabilities 60.8 46.9
Total liabilities 782.5 830.4
Commitments and Contingencies (Note 19)
STOCKHOLDERS’ EQUITY    
Common Stock, 825,000,000 shares authorized, $0.0001 par value, 147,280,524 and 146,861,489 shares issued as of December 28, 2024 and December 30, 2023, respectively 0.0 0.0
Treasury stock, at cost, 7,276,549 and 34,297 shares as of December 28, 2024 and December 30, 2023, respectively (81.4) (0.4)
Additional paid in capital 299.7 289.0
Accumulated other comprehensive loss (3.8) (2.9)
Retained earnings 304.3 233.9
Total stockholders’ equity 518.8 519.6
Total liabilities and stockholders’ equity $ 1,301.3 $ 1,350.0